BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38203538)

  • 1. Modulation of TRPV1 and TRPA1 Channels Function by Sea Anemones' Peptides Enhances the Viability of SH-SY5Y Cell Model of Parkinson's Disease.
    Kolesova YS; Stroylova YY; Maleeva EE; Moysenovich AM; Pozdyshev DV; Muronetz VI; Andreev YA
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of TRPM7, TRPM8, and TRPV1 channels modulate apoptotic parameters and neurodegenerative markers: Focus on neuronal differentiation and Parkinson's disease model.
    Öz A; Çelik Ö
    Cell Biol Int; 2023 Sep; 47(9):1502-1518. PubMed ID: 37208975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease.
    Mazzocchi M; Goulding SR; Wyatt SL; Collins LM; Sullivan AM; O'Keeffe GW
    Mol Cell Neurosci; 2021 Sep; 115():103642. PubMed ID: 34119632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.
    Melo TQ; van Zomeren KC; Ferrari MF; Boddeke HW; Copray JC
    Exp Brain Res; 2017 Mar; 235(3):731-742. PubMed ID: 27866262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of neuronal cell differentiation on TRPM7, TRPM8 and TRPV1 channels in the model of Parkinson's disease.
    Öz A; Çelik Ö
    Neurol Res; 2022 Jan; 44(1):24-37. PubMed ID: 34256685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein Overexpression in SH-SY5Y Human Neuroblastoma Cells Leads to the Accumulation of Thioflavin S-positive Aggregates and Impairment of Glycolysis.
    Melnikova A; Pozdyshev D; Barinova K; Kudryavtseva S; Muronetz VI
    Biochemistry (Mosc); 2020 May; 85(5):604-613. PubMed ID: 32571190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
    Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.
    Chorfa A; Bétemps D; Morignat E; Lazizzera C; Hogeveen K; Andrieu T; Baron T
    Toxicol Sci; 2013 Jun; 133(2):289-97. PubMed ID: 23535362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the TRPM2 Channel Expression in Human Neuroblastoma SH-SY5Y Cells Augments the Susceptibility to ROS-Induced Cell Death.
    An X; Fu Z; Mai C; Wang W; Wei L; Li D; Li C; Jiang LH
    Cells; 2019 Jan; 8(1):. PubMed ID: 30625984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic Acid-Differentiated Neuroblastoma SH-SY5Y Is an Accessible In Vitro Model to Study Native Human Acid-Sensing Ion Channels 1a (ASIC1a).
    Kalinovskii AP; Osmakov DI; Koshelev SG; Lubova KI; Korolkova YV; Kozlov SA; Andreev YA
    Biology (Basel); 2022 Jan; 11(2):. PubMed ID: 35205034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cell-based model of alpha-synucleinopathy for screening compounds with therapeutic potential of Parkinson's disease.
    Zhao DL; Zou LB; Zhou LF; Zhu P; Zhu HB
    Acta Pharmacol Sin; 2007 May; 28(5):616-26. PubMed ID: 17439717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy.
    Jiang TF; Zhang YJ; Zhou HY; Wang HM; Tian LP; Liu J; Ding JQ; Chen SD
    J Neuroimmune Pharmacol; 2013 Mar; 8(1):356-69. PubMed ID: 23325107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.
    Marwarha G; Rhen T; Schommer T; Ghribi O
    J Neurochem; 2011 Dec; 119(5):1119-36. PubMed ID: 21951066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease.
    Sun Q; Zhang Y; Wang S; Yang F; Cai H; Xing Y; Zhou L; Chen S; Wang Y
    Exp Cell Res; 2022 Aug; 417(1):113132. PubMed ID: 35398161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
    Lev N; Melamed E; Offen D
    Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson's disease.
    Lu J; Wang C; Cheng X; Wang R; Yan X; He P; Chen H; Yu Z
    J Neuroinflammation; 2022 May; 19(1):113. PubMed ID: 35599331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.
    Zhong J; Li M; Xu J; Dong W; Qin Y; Qiu S; Li X; Wang H
    Toxicol Appl Pharmacol; 2022 Feb; 436():115859. PubMed ID: 34990728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.